Janssen

TREMFYA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TREMFYA – J1628

Manufacturer:

Janssen

Name:

TREMFYA

HCPCS Code Descriptor:

Injection, guselkumab, 1 mg

Category:

J Code

HCPCS:

J1628

NDC(s):

57894-0640-01, 57894-0640-11

Primary Type:

Immunology:Anti-TNF

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

TREMFYA is an Immunology:Anti-TNF drug manufactured by Janssen and administered via the Subcutaneous route of administration. The J Code: J1628 is aligned to the drug TREMFYA.

Tremfya is a monoclonal antibody that is used to treat certain skin and joint conditions. It works by blocking a certain protein which causes immune responses and is administered via subcutaneous injection. Tremfya is a branded drug manufactured by Janssen Biotech. Prior to receiving its J Code: J1628 in January 2019, Tremfya was aligned to the C Code: C9029.Patient assistance programs for Tremfya can be found through the Johnson & Johnson Patient Assistance Program.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Inj., guselkumab, 1 mg

Billing and Coding Guide:

https://www.janssencarepath.com/hcp/tremfya/reimbursement/coding-billing

Patient Assistance:

https://www.jjpaf.org/apply/